Limited Success With Myelin Rebuilder in Optic Neuritis
Six weeks of treatment in a midstage clinical trial with a potential remyelination agent led to increases in a measure of optic nerve conduction in patients with acute optic neuritis, a condition often seen in conjunction with multiple sclerosis, the ...
MedPage Today - Thu, 08 Jan 2015 10:11

Biogen Reveals Positive Data from Acute Optic Neuritis Study
Zacks.com - Fri, 09 Jan 2015 13:33

Biogen Idec anti-LINGO-1 data in acute optic neuritis whet appetites for more
BioWorld Online - Thu, 08 Jan 2015 18:37

UPDATE 2-Biogen experimental drug shows evidence of optic nerve repair
Reuters - Thu, 08 Jan 2015 05:41

Biogen announces top-line results from phase 2 acute optic neuritis RENEW trial
pharmabiz.com - Fri, 09 Jan 2015 23:30

Biogen shares fall after optic nerve study results seen as mixed
Yahoo News - Thu, 08 Jan 2015 05:12

Biogen's Nerve Repair Drug Yields Mixed Results in Key Eye Trial
TheStreet.com - Thu, 08 Jan 2015 05:35

National Multiple Sclerosis Society Funds Bionure's Optic Neuritis Treatment ...
If successful, the preclinical results will enable Bionure to file for an Investigational New Drug application with the US Food and Drug Administration to validate a subsequent Phase I clinical trial in Acute Optic Neuritis (AON), a condition known to ...
Multiple Sclerosis News Today - Mon, 12 Jan 2015 03:39



Remyelination Agent for Optic Neuritis Shows Limited Success
Results of a phase II trial of a potential remyelination agent indicated it improved recovery of optic nerve latency, but other study endpoints were not achieved, according to a press release from Biogen Idec. The participants were treated for acute ...
Neurology Advisor - Mon, 12 Jan 2015 07:56

Study: Anti-LINGO-1 shows evidence of repair of visual system in acute optic ...
Healio - Mon, 12 Jan 2015 11:10



Google, Biogen team up for multiple sclerosis research
“We used to see patients at the beginning stages of MS — two women would come in with optic neuritis, they couldn't see out of one eye, they'd have some spots on the MRI scan, and they looked very similar,” said Rudick, who previously was director of ...
SFGate - Tue, 27 Jan 2015 14:41



Speaking LINGO, Biogen R&D Chief Wants to Push Nerve Repair Boundary
In the Phase 2a data released earlier this month, Biogen tested BIIB-033 in patients with acute optic neuritis (AON), an attack on the optic nerve that is often the first acute symptom to afflict a MS patient. (UCSF's Green says 25 to 30 percent of all ...
Xconomy - Mon, 26 Jan 2015 04:56



Medical Dictionary: Devic's disease
Devic's disease, known as neuromyelitis optica, is a central nervous system disorder that causes swelling and inflammation of the eye nerves (optic neuritis) and the spinal cord (myelitis). The cause of the disease is unknown, thought it may sometimes ...
The News Journal - Sun, 25 Jan 2015 21:03

Bionure and National Multiple Sclerosis Society Enter into a Collaboration to ...
Under this agreement, Fast Forward will provide funding to Bionure for the late-preclinical development of BN201 to enable IND filling to support the Phase 1 clinical study in Acute Optic Neuritis (AON). Optic neuritis is often a first sign of multiple ...
Business Wire (press release) - Fri, 09 Jan 2015 15:48



Treatment of Multiple Sclerosis gets a boost from Collaboration
According to the terms disclosed, Bionure will obtain funding from Fast Forward for “the late-preclinical development of BN201 to enable IND filling to support the Phase 1 clinical study in Acute Optic Neuritis (AON). Optic neuritis is often a first ...
Newstar Media - Sat, 10 Jan 2015 13:35


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014